Related references
Note: Only part of the references are listed.Amphiphilic Tobramycins with Immunomodulatory Properties
Goutam Guchhait et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455
Venkateswarlu Yarlagadda et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
In vivo efficacy and pharmacological properties of a novel glycopeptide (W4465) against vancomycin-intermediate Staphylococcus aureus
Venkateswarlu Yarlagadda et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens
Sabesan Yoganathan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Tackling vancomycin-resistant bacteria with 'lipophilic-vancomycin-carbohydrate conjugates'
Venkateswarlu Yarlagadda et al.
JOURNAL OF ANTIBIOTICS (2015)
Glycopeptide antibiotics: Back to the future
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2014)
Membrane Active Phenylalanine Conjugated Lipophilic Norspermidine Derivatives with Selective Antibacterial Activity
Mohini M. Konai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Membrane Active Vancomycin Analogues: A Strategy to Combat Bacterial Resistance
Venkateswarlu Yarlagadda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!
Chandradhish Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Enterobactin-Mediated Delivery of β-Lactam Antibiotics Enhances Antibacterial Activity against Pathogenic Escherichia coli
Tengfei Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Discovery of a New Class of Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity
Peter I. O'Daniel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Small cationic antimicrobial peptides delocalize peripheral membrane proteins
Michaela Wenzel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dendrimer-Based Multivalent Vancomycin Nanoplatform for Targeting the Drug-Resistant Bacterial Surface
Seok Ki Choi et al.
ACS NANO (2013)
Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
Kieron M. G. O'Connell et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents
Divakara S. S. M. Uppu et al.
CHEMICAL COMMUNICATIONS (2013)
The emerging problem of linezolid-resistant Staphylococcus
Bing Gu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Activated ClpP kills persisters and eradicates a chronic biofilm infection
B. P. Conlon et al.
NATURE (2013)
Identifying producers of antibacterial compounds by screening for antibiotic resistance
Maulik N. Thaker et al.
NATURE BIOTECHNOLOGY (2013)
Platforms for antibiotic discovery
Kim Lewis
NATURE REVIEWS DRUG DISCOVERY (2013)
Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates
Ute Bertsche et al.
PLOS ONE (2013)
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
Jose Ruben Morones-Ramirez et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Redesign of Glycopeptide Antibiotics: Back to the Future
Robert C. James et al.
ACS CHEMICAL BIOLOGY (2012)
Recent advances in the synthesis of new glycopeptide antibiotics
Polly-Anna Ashford et al.
CHEMICAL SOCIETY REVIEWS (2012)
Total Synthesis of [Ψ[C(=S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(=NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding
Jian Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Design and synthesis of unprecedented cyclic γ-AApeptides for antimicrobial development
Haifan Wu et al.
CHEMICAL SCIENCE (2012)
A Redesigned Vancomycin Engineered for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
Jian Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Tackling antibiotic resistance
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2011)
New Lipoglycopeptides A Comparative Review of Dalbavancin, Oritavancin and Telavancin
George G. Zhanel et al.
DRUGS (2010)
Discovery of a Novel Series of Semisynthetic Vancomycin Derivatives Effective against Vancomycin-Resistant Bacteria
Yuki Nakama et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization
Oscar Domenech et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
Geoffrey A. McKay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Sungwook Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antibiotics for Emerging Pathogens
Michael A. Fischbach et al.
SCIENCE (2009)
Anti-MRSA agent discovery using diversity-oriented synthesis
Gemma L. Thomas et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
The bacterial envelope as a target for novel anti-MRSA antibiotics
Francoise Van Bambeke et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Mimicry of antimicrobial host-defense peptides by random copolymers
Brendan P. Mowery et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Ultrashort antibacterial and antifungal lipopeptides
Arik Makovitzki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Glycopeptide and lipoglycopeptide antibiotics
D Kahne et al.
CHEMICAL REVIEWS (2005)
Antibacterial resistance worldwide: causes, challenges and responses
SB Levy et al.
NATURE MEDICINE (2004)
Antibiotic optimization via in vitro glycorandomization
X Fu et al.
NATURE BIOTECHNOLOGY (2003)
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus
LM Weigel et al.
SCIENCE (2003)
Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions
CC McComas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers
JH Griffin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate
L Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Vancomycin assembly: Nature's way
BK Hubbard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Share Paper
